StockData
Moderna, Inc. logo

Moderna, Inc. (MRNA) stock

MRNANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30537% above fair value
$196.79−10.01 (-4.84%)

Close on Nov 18, 2026Market cap $78.57BP/E –Yield –

Moderna revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

Moderna's revenue for the twelve months ending Jun 30, 2026 was $2.23B, down 27.6% year over year. For fiscal 2025 it was $1.94B, down 39.9% from the year before. The highest annual figure on record is $19.26B in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.94B-39.9%
FY2024Dec 31, 2024$3.24B-52.7%
FY2023Dec 31, 2023$6.85B-64.4%
FY2022Dec 31, 2022$19.26B+4.3%
FY2021Dec 31, 2021$18.47B+2200.2%
FY2020Dec 31, 2020$803.00M+1238.3%
FY2019Dec 31, 2019$60.00M-55.6%
FY2018Dec 31, 2018$135.07M-34.4%
FY2017Dec 31, 2017$205.83M+89.9%
FY2016Dec 31, 2016$108.40M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$145.00M+2.1%
Q1 FY2026Mar 31, 2026$389.00M+260.2%
Q4 FY2025Dec 31, 2025$678.00M-29.8%
Q3 FY2025Sep 30, 2025$1.02B-45.4%
Q2 FY2025Jun 30, 2025$142.00M-41.1%
Q1 FY2025Mar 31, 2025$108.00M-35.3%
Q4 FY2024Dec 31, 2024$966.00M-65.6%
Q3 FY2024Sep 30, 2024$1.86B+1.7%
Q2 FY2024Jun 30, 2024$241.00M-29.9%
Q1 FY2024Mar 31, 2024$167.00M-91.0%
Q4 FY2023Dec 31, 2023$2.81B-44.7%
Q3 FY2023Sep 30, 2023$1.83B-45.6%
Q2 FY2023Jun 30, 2023$344.00M-92.8%
Q1 FY2023Mar 31, 2023$1.86B-69.3%
Q4 FY2022Dec 31, 2022$5.08B-29.5%
Q3 FY2022Sep 30, 2022$3.36B-32.3%
Q2 FY2022Jun 30, 2022$4.75B+9.1%
Q1 FY2022Mar 31, 2022$6.07B+213.2%
Q4 FY2021Dec 31, 2021$7.21B+1162.9%
Q3 FY2021Sep 30, 2021$4.97B+3065.0%
Q2 FY2021Jun 30, 2021$4.35B+6398.5%
Q1 FY2021Mar 31, 2021$1.94B+24112.5%
Q4 FY2020Dec 31, 2020$571.00M+3962.6%
Q3 FY2020Sep 30, 2020$157.00M+821.0%
Q2 FY2020Jun 30, 2020$67.00M+412.1%
Q1 FY2020Mar 31, 2020$8.00M-50.1%
Q4 FY2019Dec 31, 2019$14.06M-60.3%
Q3 FY2019Sep 30, 2019$17.05M-59.2%
Q2 FY2019Jun 30, 2019$13.08M-54.7%
Q1 FY2019Mar 31, 2019$16.03M-44.8%
Q4 FY2018Dec 31, 2018$35.42M-61.5%
Q3 FY2018Sep 30, 2018$41.76M-1.7%
Q2 FY2018Jun 30, 2018$28.85M-29.8%
Q1 FY2018Mar 31, 2018$29.04M-4.3%
Q4 FY2017Dec 31, 2017$91.90M–
Q3 FY2017Sep 30, 2017$42.47M–
Q2 FY2017Jun 30, 2017$41.12M–
Q1 FY2017Mar 31, 2017$30.33M–

More Moderna figures

See a number that looks wrong?